Nada, I Ketut Wibawa
Unknown Affiliation

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

The use of echocardiography as a routine perioperative monitoring standard: The perspective of a cardiothoracic anesthesiologist Nada, I Ketut Wibawa; Pradhana, Adinda Putra
Bali Journal of Anesthesiology Vol 3, No 1 (2019)
Publisher : DiscoverSys Inc.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (161.163 KB) | DOI: 10.15562/bjoa.v3i1.144

Abstract

INTRODUCTIONIn the era of medicine that has been very advanced as it is today, we as anesthesiologists are required to be able to provide anesthetic services that are comfortable but still safe. Throughout the world, there are more than 300 million major surgery each year, and major cardiovascular adverse events are a significant cause of perioperative morbidity and mortality.1 This certainly relates to the nature of anesthetic agents that are mostly cardiovascular-depressant. Anesthetic agents such as propofol, ketamine, opioids, inhalation anesthetic agents, and many others, can directly affect the cardiovascular system.2While the major cardiac event occurred during perioperative events is also quite high. Especially for the patients in the perioperative period who will undergo non-cardiac surgery. This frequently reduces the alertness of an anesthesiologist, especially when performing perioperative monitoring. A study from Smilowitz et al.,1 showed that out of 10,581,621 patients admitted to hospital for major non-cardiac surgery plans, 317,479 (3%) patients had experienced major cardiac events. Which can be illustrated that major cardiac events occur in 1 in 33 patients treated for major non-cardiac surgery. Echocardiography is a safe, relatively inexpensive and well-tolerated action for patients.3Regular use of echocardiography in the perioperative period can certainly help to predict and even reduce major events adverse cardiac events. It is good to be used as a guide for making decisions in carrying out actions, as well as for monitoring the patient's condition regularly during the perioperative period. The use of echocardiography so far has been used for both diagnosis and management in the field of cardiology and is used by another specialist as well, although anesthesiologists do not use it in the perioperative period as a routine manner. Meanwhile, the role of an anesthesiologist as a perioperative doctor has become something that other specialties have begun to rely on.4
Isobaric levobupivacaine for intrathecal anesthesia as an effective and safe option in transurethral resection of the prostate surgery Senapathi, Tjokorda Gde Agung; Widnyana, I Made Gede; Nada, I Ketut Wibawa; Astuti, Mira Kusuma
Bali Journal of Anesthesiology Vol 3, No 2 (2019)
Publisher : DiscoverSys Inc.

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (183.448 KB) | DOI: 10.15562/bjoa.v3i2.187

Abstract

The search for safer anesthetic solutions has always been one of the primary needs in anesthesiology practice. Levobupivacaine, the pure S (-) enantiomer of bupivacaine, emerged as a safer alternative for intrathecal anesthesia than its racemic parent (bupivacaine). Levobupivacaine shows a lower risk of the central nervous system and cardiovascular toxicity.However, in many countries, levobupivacaine is only available in isobaric solution, where the isobaric solution for intrathecal anesthesia is still often be questioned its effectiveness because of the fear that the block spreading is unpredictable. In this case series, we describe sensory and motor block characteristics, hemodynamics profile and adverse effects of isobaric levobupivacaine in intrathecal anesthesia for six patients with American Society of Anesthesiology physical status II-III whose undergo transurethral endoscopic surgery.
Efektivitas dan Risiko Pemberian Antibiotik Profilaksis Ceftriaxone pada Pasien Cedera Otak Akut: Tinjauan Naratif Pita, Mora Lesmana; Suranadi, I Wayan; Nada, I Ketut Wibawa
Jurnal Anestesiologi dan Terapi Intensif Vol. 1 No. 3 (2025): JATI Desember 2025
Publisher : Udayana University and Indonesian Society of Anesthesiologists (PERDATIN)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24843/ygnrw562

Abstract

Cedera otak akut merupakan salah satu penyebab utama mortalitas dan morbiditas pada pasien trauma dan sering disertai komplikasi infeksi nosokomial seperti ventilator-associated pneumonia (VAP) dan meningitis. Penggunaan antibiotik profilaksis, termasuk ceftriaxone, banyak diterapkan untuk mencegah komplikasi tersebut karena spektrum kerjanya yang luas dan kemampuannya menembus sistem saraf pusat. Namun, efektivitas dan dampak terhadap resistensi antimikroba masih menjadi perdebatan, terutama dalam konteks praktik intensif dan bedah saraf. Tinjauan naratif ini bertujuan untuk menilai efektivitas, keamanan, dan implikasi klinis pemberian ceftriaxone sebagai antibiotik profilaksis pada pasien cedera otak akut. Berdasarkan hasil uji klinis acak dan kajian sistematis, ceftriaxone menunjukkan penurunan kejadian VAP dini sebesar 14% dibandingkan 32% pada kelompok kontrol, tetapi tidak menunjukkan manfaat signifikan terhadap pencegahan meningitis atau infeksi luka operasi. Beberapa studi juga melaporkan peningkatan risiko resistensi bakteri akibat pemberian berkepanjangan. Hasil sintesis ini menegaskan pentingnya pendekatan selektif dalam pemberian antibiotik profilaksis dengan mempertimbangkan risiko infeksi dan prinsip antimicrobial stewardship. Pesan utama dari tinjauan ini adalah perlunya kebijakan penggunaan antibiotik yang lebih rasional dan penelitian prospektif untuk menentukan populasi pasien yang paling diuntungkan serta durasi optimal pemberian profilaksis.
Efektivitas dan Risiko Pemberian Antibiotik Profilaksis Ceftriaxone pada Pasien Cedera Otak Akut: Tinjauan Naratif Pita, Mora Lesmana; Suranadi, I Wayan; Nada, I Ketut Wibawa
Jurnal Anestesiologi dan Terapi Intensif Vol. 1 No. 3 (2025): JATI Desember 2025
Publisher : Udayana University and Indonesian Society of Anesthesiologists (PERDATIN)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24843/ygnrw562

Abstract

Cedera otak akut merupakan salah satu penyebab utama mortalitas dan morbiditas pada pasien trauma dan sering disertai komplikasi infeksi nosokomial seperti ventilator-associated pneumonia (VAP) dan meningitis. Penggunaan antibiotik profilaksis, termasuk ceftriaxone, banyak diterapkan untuk mencegah komplikasi tersebut karena spektrum kerjanya yang luas dan kemampuannya menembus sistem saraf pusat. Namun, efektivitas dan dampak terhadap resistensi antimikroba masih menjadi perdebatan, terutama dalam konteks praktik intensif dan bedah saraf. Tinjauan naratif ini bertujuan untuk menilai efektivitas, keamanan, dan implikasi klinis pemberian ceftriaxone sebagai antibiotik profilaksis pada pasien cedera otak akut. Berdasarkan hasil uji klinis acak dan kajian sistematis, ceftriaxone menunjukkan penurunan kejadian VAP dini sebesar 14% dibandingkan 32% pada kelompok kontrol, tetapi tidak menunjukkan manfaat signifikan terhadap pencegahan meningitis atau infeksi luka operasi. Beberapa studi juga melaporkan peningkatan risiko resistensi bakteri akibat pemberian berkepanjangan. Hasil sintesis ini menegaskan pentingnya pendekatan selektif dalam pemberian antibiotik profilaksis dengan mempertimbangkan risiko infeksi dan prinsip antimicrobial stewardship. Pesan utama dari tinjauan ini adalah perlunya kebijakan penggunaan antibiotik yang lebih rasional dan penelitian prospektif untuk menentukan populasi pasien yang paling diuntungkan serta durasi optimal pemberian profilaksis.